These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 19334376)

  • 21. Antimicrobial susceptibility testing of Brucella melitensis isolated from patients with acute brucellosis in a centre of Iran.
    Razzaghi R; Rastegar R; Momen-Heravi M; Erami M; Nazeri M
    Indian J Med Microbiol; 2016; 34(3):342-5. PubMed ID: 27514957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergy tests by E test and checkerboard methods of antimicrobial combinations against Brucella melitensis.
    Orhan G; Bayram A; Zer Y; Balci I
    J Clin Microbiol; 2005 Jan; 43(1):140-3. PubMed ID: 15634962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting Brucella melitensis with polymeric nanoparticles containing streptomycin and doxycycline.
    Seleem MN; Jain N; Pothayee N; Ranjan A; Riffle JS; Sriranganathan N
    FEMS Microbiol Lett; 2009 May; 294(1):24-31. PubMed ID: 19493005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro susceptibility of clinical isolates of Brucella melitensis to fucidic acid.
    Celik I; Cihangiroglu M; Denk A; Akbulut A
    J Infect Chemother; 2005 Apr; 11(2):101-3. PubMed ID: 15856380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of antimycobacterial drugs with the anti-Mycobacterium avium complex effects of antimicrobial effectors, reactive oxygen intermediates, reactive nitrogen intermediates, and free fatty acids produced by macrophages.
    Sano K; Tomioka H; Sato K; Sano C; Kawauchi H; Cai S; Shimizu T
    Antimicrob Agents Chemother; 2004 Jun; 48(6):2132-9. PubMed ID: 15155211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro susceptibilities of Brucella melitensis isolates to eleven antibiotics.
    Turkmani A; Ioannidis A; Christidou A; Psaroulaki A; Loukaides F; Tselentis Y
    Ann Clin Microbiol Antimicrob; 2006 Oct; 5():24. PubMed ID: 17014707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effector molecules of the host defence mechanism against Mycobacterium avium complex: the evidence showing that reactive oxygen intermediates, reactive nitrogen intermediates, and free fatty acids each alone are not decisive in expression of macrophage antimicrobial activity against the parasites.
    Tomioka H; Sato K; Sano C; Akaki T; Shimizu T; Kajitani H; Saito H
    Clin Exp Immunol; 1997 Aug; 109(2):248-54. PubMed ID: 9276519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro antimicrobial susceptibility of Brucella melitensis isolates from sheep in an area endemic for human brucellosis in Turkey.
    Ilhan Z; Solmaz H; Ekin IH
    J Vet Med Sci; 2013; 75(8):1035-40. PubMed ID: 23545462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and Diagnostic Aspects of Brucellosis and Antimicrobial Susceptibility of Brucella Isolates in Hamedan, Iran.
    Torkaman Asadi F; Hashemi SH; Alikhani MY; Moghimbeigi A; Naseri Z
    Jpn J Infect Dis; 2017 May; 70(3):235-238. PubMed ID: 27580575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prosthetic hip infection due to Brucella melitensis: case report and literature review.
    Tena D; Romanillos O; Rodríguez-Zapata M; de la Torre B; Pérez-Pomata MT; Viana R; Chaves JM; Bisquert J
    Diagn Microbiol Infect Dis; 2007 Aug; 58(4):481-5. PubMed ID: 17509788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro assay for the anti-Brucella activity of medicinal plants against tetracycline-resistant Brucella melitensis.
    Motamedi H; Darabpour E; Gholipour M; Seyyed Nejad SM
    J Zhejiang Univ Sci B; 2010 Jul; 11(7):506-11. PubMed ID: 20593515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antimicrobial susceptibilities of Brucella isolates from various clinical specimens.
    Bayram Y; Korkoca H; Aypak C; Parlak M; Cikman A; Kilic S; Berktas M
    Int J Med Sci; 2011 Mar; 8(3):198-202. PubMed ID: 21448305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro bactericidal activity of aminoglycosides, including the next-generation drug plazomicin, against Brucella spp.
    Olsen SC; Carlson SA
    Int J Antimicrob Agents; 2015 Jan; 45(1):76-8. PubMed ID: 25459738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MLVA typing and antibiotic susceptibility of Brucella human isolates from Liaoning, China.
    Jiang H; Mao LL; Zhao HY; Li LY; Piao DR; Yao WQ; Cui BY
    Trans R Soc Trop Med Hyg; 2010 Dec; 104(12):796-800. PubMed ID: 20832094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro synergistic effects of a short cationic peptide and clinically used antibiotics against drug-resistant isolates of Brucella melitensis.
    Mohammadi Azad Z; Moravej H; Fasihi-Ramandi M; Masjedian F; Nazari R; Mirnejad R; Moosazadeh Moghaddam M
    J Med Microbiol; 2017 Jul; 66(7):919-926. PubMed ID: 28699872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of long-term ethanol feeding on efficacy of doxycycline plus rifampicin in the treatment of experimental brucellosis caused by Brucella melitensis in rats.
    Yumuk Z; Dundar V
    J Chemother; 2005 Oct; 17(5):509-13. PubMed ID: 16323439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reactive nitrogen intermediates have a bacteriostatic effect on Mycobacterium tuberculosis in vitro.
    Firmani MA; Riley LW
    J Clin Microbiol; 2002 Sep; 40(9):3162-6. PubMed ID: 12202547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of ciprofloxacin versus doxycycline as prophylaxis against experimental murine Brucella melitensis infection.
    Atkins HS; Spencer S; Brew SD; Jenner DC; Russell P; MacMillan AP; Eley SM; Simpson AJ
    Int J Antimicrob Agents; 2009 Nov; 34(5):474-6. PubMed ID: 19500948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Compensatory increase in ahpC gene expression and its role in protecting Burkholderia pseudomallei against reactive nitrogen intermediates.
    Loprasert S; Sallabhan R; Whangsuk W; Mongkolsuk S
    Arch Microbiol; 2003 Dec; 180(6):498-502. PubMed ID: 14614594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mycobacterium tuberculosis CDC1551 is resistant to reactive nitrogen and oxygen intermediates in vitro.
    Firmani MA; Riley LW
    Infect Immun; 2002 Jul; 70(7):3965-8. PubMed ID: 12065545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.